Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This randomized phase II trial is studying how well megestrol works in treating patients with
endometrial neoplasia or endometrial hyperplasia. Estrogen can cause the growth of
endometrial cancer cells. Hormone therapy using megestrol may fight endometrial cancer by
blocking the use of estrogen by the abnormal cells.